Association and predictive accuracy of high TSH serum levels in first trimester and adverse pregnancy outcomes

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages 3115-3122

  Schneuer, Francisco J ^a   Nassar, Natasha ^a   Tasevski, Vitomir ^a,b   Morris, Jonathan M ^a,b   Roberts, Christine L ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; SCREENING TEST; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; STILLBIRTH; THYROTROPIN BLOOD LEVEL;

ABORTION, SPONTANEOUS; ADULT; AREA UNDER CURVE; AUSTRALIA; BODY WEIGHT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; MATERNAL AGE; MEDICAL RECORD LINKAGE; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; ROC CURVE; SMOKING; STILLBIRTH; THYROTROPIN;

EID: 84866155079     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1193     Document Type: Article

References (39)

1. Kennedy RL, Malabu UH, Jarrod G, Nigam P, Kannan K, Rane A 2010 Thyroid function and pregnancy: before, during and beyond. J Obstet Gynaecol 30:774-783
2. Burrow GN, Fisher DA, Larsen PR 1994 Maternal and fetal thyroid function. N Engl J Med 331:1072-1078
3. Maruo T, Matsuo H, Mochizuki M 1991 Thyroid hormone as a biological amplifier of differentiated trophoblast function in early pregnancy. Acta Endocrinol (Copenh) 125:58-66
4. Loubière LS, Vasilopoulou E, Bulmer JN, Taylor PM, Stieger B, Verrey F, McCabe CJ, Franklyn JA, Kilby MD, Chan SY 2010 Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta 31:295-304
5. Lazarus JH 1999 Thyroid hormones and neurodevelopment. Clin Endocrinol (Oxf) 50:147-148
6. Morreale de Escobar G, Obregon MJ, Escobar del Rey F 2004 Role of thyroid hormone during early brain development. Eur J Endocrinol 151(Suppl 3):U25-U37 (Pubitemid 39627053)
7. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ 1999 Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341:549-555 (Pubitemid 29384162)
8. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ 2003 Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 59:282-288 (Pubitemid 37046980)
9. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ 2004 Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228-238 (Pubitemid 38082818)
10. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ, Vrijkotte TG 2009 Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 160:985-991
11. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A 2010 Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 95:E44-E48
12. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, Cunningham FG 2005 Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105:239-245 (Pubitemid 40229436)
13. Ashoor G, Maiz N, Rotas M, Kametas NA, Nicolaides KH 2010 Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia. Prenat Diagn 30:1032-1038
14. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, Luthy D, Gross S, Bianchi DW, D'Alton ME 2008 Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 112:85-92
15. Männistö T, Vääräsmäki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, Bloigu A, Järvelin MR, Suvanto E 2010 Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab 95:1084-1094
16. Dosiou C, Barnes J, Schwartz A, Negro R, Crapo L, Stagnaro-Green A 2012 Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab 97:1536-1546
17. Thung SF, Funai EF, Grobman WA 2009 The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstet Gynecol 200:267.e1-e7
18. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A 2010 Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 95:1699-1707
19. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W 2011 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21:1081-1125
20. Centre for Epidemiology and Research, NSW Department of Health 2010 New South Wales Mothers and Babies 2007. NSW Public Health Bull Vol. 21(S1):1-156
21. Méray N, Reitsma JB, Ravelli AC, Bonsel GJ 2007 Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number. J Clin Epidemiol 60:883-891
22. Declercq E, Barger M, Cabral HJ, Evans SR, Kotelchuck M, Simon C, Weiss J, Heffner LJ 2007 Maternal outcomes associated with planned primary cesarean births compared with planned vaginal births. Obstet Gynecol 109:669-677 (Pubitemid 46339407)
23. Ford JB, Roberts CL, Algert CS, Bowen JR, Bajuk B, Henderson-Smart DJ 2007 Using hospital discharge data for determining neonatal morbidity and mortality: a validation study. BMC Health Serv Res 7:188
24. Roberts CL, Lancaster PA 1999 Australian national birthweight percentiles by gestational age. Med J Aust 170:114-118 (Pubitemid 29060342)
25. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM 2001 The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20:IX-XIV (Pubitemid 32672922)
26. Lain SJ, Algert CS, Tasevski V, Morris JM, Roberts CL 2009 Record linkage to obtain birth outcomes for the evaluation of screening biomarkers in pregnancy: a feasibility study. BMC Med Res Methodol 9:48
27. Roberts CL, Bell JC, Ford JB, Hadfield RM, Algert CS, Morris JM 2008 The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertens Pregnancy 27:285-297
28. Cuckle H, Wald NJ 2000 Principles of screening. In: Wald N, Leck I, eds. Antenatal and neonatal screening. 2nd ed. Oxford, UK: Oxford University Press; 3-22
29. Swets JA 1988 Measuring the accuracy of diagnostic systems. Science 240:1285-1293
30. Prummel MF, Wiersinga WM 2004 Thyroid autoimmunity and miscarriage. Eur J Endocrinol 150:751-755 (Pubitemid 38961646)
31. Simmons LE, Rubens CE, Darmstadt GL, Gravett MG 2010 Preventing preterm birth and neonatal mortality: exploring the epidemiology, causes, and interventions. Semin Perinatol 34:408-415
32. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H 2006 Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 91:2587-2591 (Pubitemid 44024622)
33. Wilcken BM, Wiley VC 2011 Increased iodine deficiency in Victoria, Australia: analysis of neonatal thyroid-stimulating hormone data, 2001 to 2006. Med J Aust 194:209-210
34. Gilbert RM, Hadlow NC, Walsh JP, Fletcher SJ, Brown SJ, Stuckey BG, Lim EM 2008 Assessment of thyroid function during pregnancy: first-trimester (weeks 9-13) reference intervals derived from Western Australian women. Med J Aust 189:250-253
35. Männistö T, Vääräsmäki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, Bloigu A, Järvelin MR, Suvanto-Luukkonen E 2009 Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 94:772-779
36. Springer D, Zima T, Limanova Z 2009 Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol 160:791-797
37. Walker JA, Illions EH, Huddleston JF, Smallridge RC 2005 Racial comparisons of thyroid function and autoimmunity during pregnancy and the postpartum period. Obstet Gynecol 106:1365-1371 (Pubitemid 41668958)
38. van Ravenswaaij R, Tesselaar-van der Goot M, de Wolf S, van Leeuwen-Spruijt M, Visser GH, Schielen PC 2011 First-trimester serum PAPP-A and fβ-hCG concentrations and other maternal characteristics to establish logistic regression-based predictive rules for adverse pregnancy outcome. Prenat Diagn 31:50-57
39. Haddow JE, McClain MR, Lambert-Messerlian G, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME 2008 Variability in thyroid-stimulating hormone suppression byhumanchorionic [corrected] gonadotropin during early pregnancy. J Clin Endocrinol Metab 93:3341-3347